Notice No20201222-45Notice Date22 Dec 2020
CategoryComplianceSegmentGeneral
SubjectOrder in the matter of IPO of HPC Biosciences Limited
Content

To

 

All Trading Members of the Exchange 

 

Sub: Order under Sections 11(1), 11(4) and 11B (1) of the Securities and Exchange Board of India Act, 1992, in the matter of IPO of HPC Biosciences Limited.

 

In continuation to the Exchange Notice Nos. 20150629-22 dated June 29, 2015, 20160218-28 dated February 18, 2016, 20160615-23 dated June 15, 2016, 20160825-33 dated August 25, 2016 and 20170906-32 dated September 6, 2017 on the captioned matter.

 

SEBI vide its order no. WTM/SM/IVD/ID3/9896/2020-21 dated December 22, 2020 has inter-alia issued following directions:

 

  • The Noticee no. 1 is hereby restrained from accessing the securities market by issuing prospectus, offer document or advertisement soliciting money from the public in any manner for a period of 8 years.

 

  • Noticee no. 2 and 3 are hereby restrained from holding post of director, any managerial position or associating themselves in any capacity with any listed public company and with any public company which intends to raise money from the public, or with any intermediary registered with SEBI for a period of 3 years.

 

  • The Noticees, as mentioned in the para 63(v) of the aforesaid Order are hereby restrained and prohibited from buying, selling or otherwise dealing in the securities market, directly or indirectly in any manner whatsoever manner, for the period specified in their respective columns.

 

  • Obligation of the debarred Noticees, in respect of settlement of securities, if any, purchased or sold in the cash segment of the recognized stock exchange(s), as existing on the date of this Order, can take place irrespective of the restraint/prohibition imposed by this Order in respect of pending transactions, if any. Further, all open positions, if any, of the aforesaid debarred Noticees in the F & O segment of the stock exchange, are permitted to be squared off, irrespective of the restraint/prohibition imposed by this Order.

 

  • It is further clarified that during the period of the aforesaid restraint, the existing holding of securities, including the units of mutual funds shall remain under freeze.

 

This Order is effective from the date of the order. 

 

A copy of the said Order is attached herewith and also available on the SEBI website www.sebi.gov.in

 

Trading members are advised to take note of the same and ensure compliance.

 

Rajesh Kumar Dubey                                                                                                  Roshani More                     

Associate Manager                                                                                                      Assistant Manager  

Surveillance                                                                                                                   Surveillance

 

Date: December 22, 2020

 

Attachments
Order in the matter of IPO of HPC Biosciences Limited.pdf